Skip Navigation
Search Menu
Heart & Vascular Institute

In This Section      
Print This Page

ARVD/C Treatments

Goals of treatment

There are two primary goals of treatment of ARVD/C:

  1. Reduce the frequency and severity of ventricular arrhythmias
  2. Prevent or limit the worsening of ventricular function and heart failure

Treatment options vary by patient, and are based on a patient’s cardiac test results, medical history, and the presence or absence of genetic mutations. The three most common treatments for arrhythmias are:

  1. Medication
  2. Implantable Cardioverter Defibrillators (ICD)
  3. Catheter Ablation

There have been no controlled studies to examine the specific effects of exercise, medications, or procedures on the long-term outcome of the disease. Nor have vitamin treatments or alternative therapies been studied. You and your doctor should discuss appropriate guidelines for diet and healthy living, as well as symptoms that could indicate a complication related to the disease.

Long-Term Outlook

Some patients will have a stable functioning heart for decades, while others may have spells of arrhythmias that require changes in medication or ablations. Our research has shown that the long-term outlook for most people with ARVD/C is relatively good. Few patients develop such severe dysfunction or frequent episodes of ventricular tachycardia that a heart transplant may be necessary. We believe that most people who die from ARVD/C do so because the condition is not diagnosed and monitored appropriately.

Do you have more questions about ARVD/C? Check out our questions and answers page.

To request an appointment with the Johns Hopkins ARVD/C Program, please contact Crystal Tichnell, MGC at 410-502-7161 or ctichnell@jhmi.edu.